Severe transient myocardial ischaemia caused by hypertrophic cardiomyopathy in a patient with congenital disorder of glycosylation type Ia

European Journal of Pediatrics

Volumn 161, Issue 10, 2002, Pages 524-527

  Marquardt, Thorsten ^a   Hülskamp, Georg ^a   Gehrmann, Josef ^a   Debus, Volker ^a   Harms, Erik ^a   Kehl, Hans ^a  

^a UNIVERSITY HOSPITAL MÜNSTER   (Germany)

Author keywords

Carbohydrate deficient glycoprotein syndrome; Congenital disorder of glycosylation; Hypertrophic cardiomyopathy; Myocardial ischaemia

Indexed keywords

ARTICLE; CARDIOVASCULAR RISK; CASE REPORT; DEHYDRATION; DISEASE SEVERITY; ECHOCARDIOGRAPHY; FATALITY; FEMALE; GLYCOSYLATION; HEART LEFT VENTRICLE OUTFLOW TRACT OBSTRUCTION; HEART MUSCLE ISCHEMIA; HUMAN; HYPERTROPHIC CARDIOMYOPATHY; INFANT; METABOLIC DISORDER; MORTALITY; MULTIPLE ORGAN FAILURE; PATIENT CARE; PATIENT MONITORING; PRIORITY JOURNAL;

CARBOHYDRATE-DEFICIENT GLYCOPROTEIN SYNDROME; CARDIOMYOPATHY, HYPERTROPHIC; ELECTROCARDIOGRAPHY; FEMALE; GLYCOSYLATION; HEART DEFECTS, CONGENITAL; HUMANS; INFANT; MYOCARDIAL ISCHEMIA; PHOSPHOTRANSFERASES (PHOSPHOMUTASES); SEVERITY OF ILLNESS INDEX; VENTRICULAR OUTFLOW OBSTRUCTION;

EID: 0036392644     PISSN: 03406199     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00431-002-1029-2     Document Type: Article

References (10)

1. Cannan CR, Reeder GS (1996) Hypertrophic cardiomyopathy: who is at risk? Acc Curr J Rev 5: 63-64
2. Clayton PT, Winchester BG, Keir G (1992) Hypertrophic obstructive cardiomyopathy in a neonate with the carbohydrate-deficient glycoprotein syndrome. J Inherit Metab Dis 15: 857-861
3. Matthijs G, Schollen E, Pardon E, Veiga-Da-Cunha M, Jaeken J, Cassimani J-J, Van Schaftingen E (1997) Mutations in PMM2, a phosphomannomutase gene on chromosome 16p13, in carbohydrate-deficient glycoprotein type I syndrome (Jaeken syndrome). Nat Genet 16: 88-92
4. Matthijs G, Schollen E, Van Schaftingen E, Cassiman J-J, Jaeken J (1998) Lack of homozygotes for the most frequent disease allele in carbohydrate-deficient glycoprotein syndrome type 1A. Am J Hum Genet 62: 542-550
5. Niehues R, Hasilik M, Alton G, Körner C, Schiebe-Sukumar M, Koch HG, Zimmer K-P, Wu R, Harms E, Reiter K, von Figura K, Freeze HH, Harms HK, Marquardt T (1998) Carbohydrate-deficient glycoprotein syndrome type Ib. Phosphomannose isomerase deficiency and mannose therapy. J Clin Invest 101: 1414-1420
6. Panza JA, Maris TJ, Maron BJ (1992) Development and determinants of dynamic obstruction to left ventricular outflow in young patients with hypertrophic cardiomyopathy. Circulation 85: 1398-1405
7. Pirard M, Matthijs G, Heykants L, Schollen E, Grünewald S, Jaeken J, Van Schaftingen E (1999) Effect of mutations found in carbohydrate-deficient glycoprotein syndrome type IA on the activity of phosphomannomutase 2. FEBS Lett 452: 319-322
8. Rush JS, Panneerselvam K, Waechter CJ, Freeze HH (2000) Mannose supplementation corrects GDP-mannose deficiency in cultured fibroblasts from some patients with congenital disorders of glycosylation (CDG). Glycobiology 10: 829-835
9. Schollen E, Kjaergaard S, Legius E, Schwartz M, Matthijs G (2000) Lack of Hardy-Weinberg equilibrium for the most prevalent PMM2 mutation in CDG-Ia (congenital disorder of glycosylation type Ia). Eur J Hum Genet 8: 367-371
10. Van Schaftingen E, Jaeken J (1995) Phosphomannomutase deficieny is a cause of carbohydrate-deficient glycoprotein syndrome type I. FEBS Lett 377: 318-320